A system for gene disruption and replacement based on a streptomycete temperate phage vector was developed to introduce DNA in the rapamycin-producing Streptomyces hygroscopicus strain ATCC 29253. This will be useful in attempts to produce, through genetic manipulation, novel forms of the therapeutically important immunosuppressive drug rapamycin. Recombinant phages were constructed from the ?31 phage derivative KC515 (c+attP) carrying a thiostrepton or viomycin resistance gene along with segments of the S. hygroscopicus chromosome. Each of the cloned segments also contained the aphll neomycin/kanamycin resistance gene to enable gene replacement by loss of the phage-derived DNA. Specific deletion of the entire polyketide synthase (PKS) believed to govern rapamycin biosynthesis resulted in the loss of rapamycin production. In contrast, disruption or deletion of a region predicted to encode four PKS open reading frames, or another region predicted to encode another PKS plus a cytochrome P450 hydroxylase and ferredoxin, had no effect on the production of rapamycin or nigericin, a polyether antibiotic also produced by S. hygroscopicus. Therefore, S. hygroscopicus may have the capacity to produce polyketides additional to rapamycin and nigericin.
AparicoJ.F.,
MolnarI.,
SchweckeT.,
KonigA.,
HaydockS.F.,
KhawL.E.,
StauntonJ.,
LeadlayP.F.1996; Organization of the biosynthetic gene cluster for rapamycin in Streptomyces hygroscopicus: analysis of the enzymatic domains in the modular polyketide synthase.. Gene 169:9–16
ButtnerM.J.,
LewisC.G.1992; Construction and characterization of Streptomyces coelicolor A3(2) mutants that are deficient in the nonessential hrd-encoded RNA polymerase sigma factor.. J Bacteriol 174:5165–5167
ChaterK.F.1986; Streptomyces phages and their application to Streptomyces genetics.. In The BacteriaIX Antibiotic producing Streptomyces pp. 119–158QueenerS.E.,
DayL.E.
Edited by Orlando, FL:: Academic Press.;
ChaterK.F.,
LomovskayaN.D.,
VoeykovaT.A.,
SladkovaI.A.,
MkrtumianN.M.,
MuravnikG.L.1986; Streptomyces øC31-like phages: cloning vectors, genome changes and host range.. In Biological, Biochemical and Biomedical Aspects of Actino- mycetes. Proceedings of the Sixth International Symposium on Actinomycete Biology pp. 45–53SzaboG.,
BiroS.,
GoodFellowM.
Edited by Budapest:: Academic Kvado.;
CortesJ.,
WiesmannK.E.H.,
RobertsG.A.,
BrownM.J.B.,
StauntonJ.,
LeadlayP.F.1995; Repositioning of a domain in a modular polyketide synthase to promote specific chain cleavage.. Science 268:1487–1489
DenisF.,
BrzezinskiR.1991; An improved aminoglycoside resistance gene cassette for use in Gram-negative bacteria and Streptomyces.. FEMS Microbiol Lett 81:261–264
DonadioS.,
McAlpineJ.B.,
SheldonP.J.,
JacksonM.,
KatzL.1993; An erythromycin analog produced by reprogramming of polyketide synthesis.. Proc Natl Acad Sci USA907119–7123
HatanakaH.,
KinoT.,
MiyataS.,
InamuraN.,
KurodaA.,
GotoT.,
TanakaH.,
OkuharaM.1988; FR-900520 and FR-900523, novel immunosuppressants isolated from a Streptomyces. II. Fermentation, isolation and physico-chemical and biological characteristics.. J Antibiot 41:1592–1601
KaoC.M.,
LuoG.,
KatzL.,
CaneD.E.,
KhoslaC.1994; Engineered biosynthesis of a triketide lactone from an incomplete modular polyketide synthase.. J Am Chem Soc 116:11612–11613
KinoT.,
HatanakaH.,
MiyataS.,
InamuraN.,
HishiyamaH.,
YajimaT.,
GotoT.,
OkuharaM.,
KohsakaM.,
AokiH.,
OchiaiT.1987; FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.. J Antibiot 40:1256–1265
LomovskayaN.,
HongS.-K.,
KimS.-U.,
FonsteinL.,
FuruyaK.,
HutchinsonC.R.1996; The Streptomyces peucetius drrC gene encodes a UvrA-like protein involved in daunorubicin resistance and production.. J Bacteriol 178:3238–3245
MelinoM.R.,
SigalN.H.1990; Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.. J Immunol 144:251–258
PiretJ.M.,
ChaterK.F.1985; Phage-mediated cloning of bldA, a region involved in Streptomyces coelicolor morphological development, and its analysis by genetic complementation.. J Bacteriol 163:965–972
VezinaC.,
KudelskiA.,
SehgalS.N.1975; Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.. J Antibiotics 28:721–726